CNS Pharmaceuticals, Inc.

Pharmaceuticals · HOUSTON, TX

PharmaceuticalsSEC Form D

CNS Pharmaceuticals, Inc. filed a Form D with the U.S. Securities and Exchange Commission on May 19, 2026, reporting $22,525,000 raised.

Incorporated in Nevada and based in HOUSTON, TX, it operates in the Pharmaceuticals sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that CNS Pharmaceuticals, Inc. has raised capital from private investors.

Browse more recently funded companies in Pharmaceuticals.

Executives & Directors

  • Rami LevinExecutive Officer · Director
  • Steve O'LoughlinExecutive Officer
  • Faith CharlesDirector
  • Michal FisherDirector
  • Jeffry KeyesDirector
  • Bettina CockroftDirector
  • Amy MaheryDirector

Recently funded in Pharmaceuticals

Other companies that recently filed a Form D

$3.0MRaised

FibroBiologics, Inc.

PharmaceuticalsHOUSTON, TX
Jun 25, 2026View SEC Form D
$200.0KRaised

Balsam Pharmaceuticals Co

PharmaceuticalsMCLEAN, VA
Jun 10, 2026View SEC Form D
$750.0KRaised

Eos SENOLYTIX, Inc.

PharmaceuticalsHOUSTON, TX
Jun 4, 2026View SEC Form D
$1.9MRaised

Liminatus Pharma, Inc.

PharmaceuticalsFULLERTON, CA
Jun 3, 2026View SEC Form D
$384.8KRaised

Spine BioPharma, Inc.

PharmaceuticalsNEW YORK, NY
May 22, 2026View SEC Form D